Clinical Trial Detail

NCT ID NCT03555149
Title A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Colorectal Cancer (Morpheus-CRC)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements yes
Sponsors Hoffmann-La Roche
Indications

colorectal cancer

Therapies

Atezolizumab

Atezolizumab + Isatuximab

Atezolizumab + Bevacizumab + PGG beta-glucan

Age Groups: senior adult

Additional content available in CKB BOOST